X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with PLETHICO PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs PLETHICO PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA PLETHICO PHARMA FULFORD INDIA/
PLETHICO PHARMA
 
P/E (TTM) x 398.8 -1.1 - View Chart
P/BV x 6.2 0.0 37,082.5% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 FULFORD INDIA   PLETHICO PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
PLETHICO PHARMA
Mar-14
FULFORD INDIA/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs942395 238.5%   
Low Rs45031 1,437.7%   
Sales per share (Unadj.) Rs691.4604.4 114.4%  
Earnings per share (Unadj.) Rs11.532.5 35.3%  
Cash flow per share (Unadj.) Rs15.451.3 29.9%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.30-  
Book value per share (Unadj.) Rs380.0473.6 80.2%  
Shares outstanding (eoy) m3.9034.08 11.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.00.4 285.5%   
Avg P/E ratio x60.76.6 925.5%  
P/CF ratio (eoy) x45.34.2 1,091.4%  
Price / Book Value ratio x1.80.5 407.0%  
Dividend payout %17.40-   
Avg Mkt Cap Rs m2,7147,262 37.4%   
No. of employees `0000.4NA-   
Total wages/salary Rs m5051,596 31.6%   
Avg. sales/employee Rs Th6,073.0NM-  
Avg. wages/employee Rs Th1,137.4NM-  
Avg. net profit/employee Rs Th100.7NM-  
INCOME DATA
Net Sales Rs m2,69620,598 13.1%  
Other income Rs m125386 32.5%   
Total revenues Rs m2,82220,984 13.4%   
Gross profit Rs m-462,818 -1.6%  
Depreciation Rs m15642 2.4%   
Interest Rs m101,593 0.6%   
Profit before tax Rs m54969 5.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10-138 -6.9%   
Profit after tax Rs m451,107 4.0%  
Gross profit margin %-1.713.7 -12.6%  
Effective tax rate %17.7-14.3 -123.7%   
Net profit margin %1.75.4 30.8%  
BALANCE SHEET DATA
Current assets Rs m1,73818,877 9.2%   
Current liabilities Rs m54511,896 4.6%   
Net working cap to sales %44.333.9 130.6%  
Current ratio x3.21.6 201.1%  
Inventory Days Days4836 134.9%  
Debtors Days Days4198 2.2%  
Net fixed assets Rs m129,861 0.1%   
Share capital Rs m39341 11.4%   
"Free" reserves Rs m1,44312,331 11.7%   
Net worth Rs m1,48216,139 9.2%   
Long term debt Rs m04,706 0.0%   
Total assets Rs m2,07733,146 6.3%  
Interest coverage x6.71.6 417.7%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.30.6 208.9%   
Return on assets %2.68.1 32.0%  
Return on equity %3.06.9 44.0%  
Return on capital %4.312.3 35.0%  
Exports to sales %021.4 0.0%   
Imports to sales %24.515.2 160.6%   
Exports (fob) Rs mNA4,402 0.0%   
Imports (cif) Rs m6593,136 21.0%   
Fx inflow Rs m174,402 0.4%   
Fx outflow Rs m6733,184 21.1%   
Net fx Rs m-6561,219 -53.8%   
CASH FLOW
From Operations Rs m902,437 3.7%  
From Investments Rs m105-6,265 -1.7%  
From Financial Activity Rs m-142,490 -0.6%  
Net Cashflow Rs m181-1,337 -13.5%  

Share Holding

Indian Promoters % 0.0 82.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 4.3 88.4%  
FIIs % 0.1 5.5 1.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 7.5 282.7%  
Shareholders   4,783 10,665 44.8%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   VENUS REMEDIES  ORCHID PHARMA LTD  SANOFI INDIA  TTK HEALTHCARE  SHASUN PHARMA  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - UNICHEM LAB COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS